EARLINE LITTLE: Open Payments
NPI 1487073219 · MC COLL, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 29 payments from 12 companies in 2025. Trend: 2023 $528 · 2024 $485 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $162 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 2 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
| Amgen Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Ozempic, Kerendia, CAPLYTA, Rybelsus, HETLIOZ, VOQUEZNA, Wegovy, GVOKE HYPOPEN.
Industry payments across SC — which companies pay providers there.
